{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:58:56Z","timestamp":1774612736564,"version":"3.50.1"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National University Ireland, Galway"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose of Review<\/jats:title>\n            <jats:p>to explore a paradigm shift in the definition of opioid-responsive cancer pain in this hypothesis-driven review. Opioid-responsive cancer pain may be misplaced within the definition of chronic pain, chronic pain takes three months to establish, early effective control is worthwhile to achieve.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent<\/jats:title>\n            <jats:p>findings, from a bench-to-bed perspective, debates the interpretation of results supporting the hypothesis that opioid-responsive cancer pain could remain \u2018constant acute pain\u2019, with explanations, best solutions, for tolerance and\/or addiction, in cancer patients compared to those with chronic pain from other conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Unraveling the unique apparent properties of opioid-responsive cancer pain empowers knowledge of the process by which acute pain may have the potential to remain acute in nature and not transition into chronic pain. Findings outlined defend the hypothesis of probable sustained acute nature of opioid-responsive cancer pain, importance of early, sustained pain control, opioid reduction and further exploration of this hypothesis in clinical practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11912-025-01642-w","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T02:01:20Z","timestamp":1743818480000},"page":"584-600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reflecting on Cancer Pain as Constant Acute Pain, not Chronic Pain. \u2018Known Knowns, Known Unknowns, Unknown Unknowns\u2019"],"prefix":"10.1007","volume":"27","author":[{"given":"Dympna","family":"Waldron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk","family":"Levins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gorey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Mannion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bairbre Mc","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doiminic \u00d3","family":"Brannag\u00e1in","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Molony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Healy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Molony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Dickenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"1642_CR1","unstructured":"I. Newton. Goodreads, Quote by Isaac Newton. https:\/\/www.goodreads.com\/quotes\/170098-what-we-know-is-a-drop-what-we-don-t-know (accessed 05\/05\/2023."},{"issue":"3","key":"1642_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpain.2016.10.020","volume":"18","author":"JA Paice","year":"2017","unstructured":"Paice JA, et al. AAPT diagnostic criteria for chronic cancer pain conditions. J pain. 2017;18(3):233\u201346.","journal-title":"J pain"},{"key":"1642_CR3","volume-title":"Cancer pain relief, ed","author":"O World Health","year":"1986","unstructured":"World Health O. Cancer pain relief, ed. Geneva: World Health Organization; 1986."},{"issue":"8","key":"1642_CR4","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/annonc\/mdp001","volume":"20","author":"H Breivik","year":"2009","unstructured":"Breivik H, et al. Cancer-related pain: a pan-european survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009;20(8):1420\u201333.","journal-title":"Ann Oncol"},{"issue":"5","key":"1642_CR5","first-page":"57","volume":"34","author":"JJ Bonica","year":"1954","unstructured":"Bonica JJ, Hoffman JF. The Management of Pain with special emphasis on the Use of Analgesic blocks in diagnosis, prognosis, and Therapy. Anesth Analgesia. 1954;34(5):57\u20138.","journal-title":"Anesth Analgesia"},{"key":"1642_CR6","doi-asserted-by":"crossref","unstructured":"Treede R-D, et al. Chronic pain as a symptom or a disease: the IASP classification of Chronic Pain for the International classification of diseases (ICD-11). Pain. 2019;160(1):19\u201327.","DOI":"10.1097\/j.pain.0000000000001384"},{"key":"1642_CR7","doi-asserted-by":"publisher","unstructured":"Fitzcharles M-A, Cohen SP, Clauw DJ, Littlejohn G, Usui C, H\u00e4user W. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet, 397, 10289, pp. 2098\u2013110,2021\/05\/29\/ 2021, doi: https:\/\/doi.org\/10.1016\/S0140-6736(21)00392-5","DOI":"10.1016\/S0140-6736(21)00392-5"},{"issue":"9","key":"1642_CR8","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1185\/03007995.2014.925439","volume":"30","author":"G M\u00fcller-Schwefe","year":"2014","unstructured":"M\u00fcller-Schwefe G, et al. Pain in the cancer patient: different pain characteristics CHANGE pharmacological treatment requirements. Curr Med Res Opin. 2014;30(9):1895\u2013908.","journal-title":"Curr Med Res Opin"},{"key":"1642_CR9","doi-asserted-by":"crossref","unstructured":"Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes, Pain, vol. 82, no. 3, pp. 263\u2013274, 1999.","DOI":"10.1016\/S0304-3959(99)00073-1"},{"issue":"16","key":"1642_CR10","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1080\/14656566.2019.1647166","volume":"20","author":"J Nijs","year":"2019","unstructured":"Nijs J, et al. Treatment of central sensitization in patients with chronic pain: time for change? Expert Opin Pharmacother. 2019;20(16):1961\u201370.","journal-title":"Expert Opin Pharmacother"},{"key":"1642_CR11","doi-asserted-by":"crossref","unstructured":"Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain, pain, vol. 152, no. 3, pp. S2-S15, 2011.","DOI":"10.1016\/j.pain.2010.09.030"},{"issue":"15","key":"1642_CR12","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.3390\/jcm10153203","volume":"10","author":"J Nijs","year":"2021","unstructured":"Nijs J, et al. Nociplastic pain criteria or recognition of central sensitization? Pain phenotyping in the past, present and future. J Clin Med. 2021;10(15):3203.","journal-title":"J Clin Med"},{"issue":"3","key":"1642_CR13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3747\/co.26.4517","volume":"26","author":"R Asthana","year":"2019","unstructured":"Asthana R, et al. Framing of the opioid problem in cancer pain management in Canada. Curr Oncol. 2019;26(3):410\u20133.","journal-title":"Curr Oncol"},{"key":"1642_CR14","doi-asserted-by":"crossref","unstructured":"Wong S-C, Cheung C-W. Optimization of opioid utility in cancer pain populations. Annals Palliat Med. 2020;9(2):558\u201370.","DOI":"10.21037\/apm.2020.03.04"},{"key":"1642_CR15","doi-asserted-by":"crossref","unstructured":"Santoni A, Santoni M, Arcuri E. Chronic cancer pain: opioids within tumor microenvironment affect neuroinflammation, tumor and pain evolution, Cancers, vol. 14, no. 9, p. 2253, 2022.","DOI":"10.3390\/cancers14092253"},{"issue":"1","key":"1642_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbi.2006.09.004","volume":"21","author":"JE Blalock","year":"2007","unstructured":"Blalock JE, Smith EM. Conceptual development of the immune system as a sixth sense. Brain Behav Immun. 2007;21(1):23\u201333.","journal-title":"Brain Behav Immun"},{"issue":"10","key":"1642_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.tins.2020.07.008","volume":"43","author":"CR Donnelly","year":"2020","unstructured":"Donnelly CR, Chen O, Ji R-R. How do sensory neurons sense danger signals? Trends Neurosci. 2020;43(10):822\u201338.","journal-title":"Trends Neurosci"},{"key":"1642_CR18","doi-asserted-by":"crossref","unstructured":"Luger NM et al. Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain, Pain, vol. 99, no. 3, pp. 397\u2013406, 2002.","DOI":"10.1016\/S0304-3959(02)00102-1"},{"key":"1642_CR19","doi-asserted-by":"crossref","unstructured":"Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain, Cell, vol. 139, no. 2, pp. 267\u2013284, 2009.","DOI":"10.1016\/j.cell.2009.09.028"},{"key":"1642_CR20","doi-asserted-by":"crossref","unstructured":"Hayes J et al. Methadone prescribed as an analgesic by a specialist palliative medicine team in an acute hospital inpatient setting: retrospective study. BMJ Supportive Palliat Care, 13, no. e3, pp. e839-e842, 2023.","DOI":"10.1136\/spcare-2022-003586"},{"key":"1642_CR21","doi-asserted-by":"publisher","first-page":"1268985","DOI":"10.3389\/fpain.2023.1268985","volume":"4","author":"S Al Mukhaizeem","year":"2023","unstructured":"Al Mukhaizeem S, et al. Investigating the effectiveness of oral ketamine on pain, mood and quality of life in treatment resistant chronic pain. Front Pain Res. 2023;4:1268985.","journal-title":"Front Pain Res"},{"issue":"29","key":"1642_CR22","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1200\/JCO.2012.42.1081","volume":"30","author":"J Hardy","year":"2012","unstructured":"Hardy J, et al. Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol. 2012;30(29):3611\u20137.","journal-title":"J Clin Oncol"},{"key":"1642_CR23","unstructured":"Team PE. EAPC 2021: The Burst Ketamine Regimen is Effective and Well Tolerated for Complex Cancer-Related Neuropathic Pain. Practice Update. https:\/\/www.practiceupdate.com\/content\/eapc-2021-the-burst-ketamine-regimen-is-effective-and-well-tolerated-for-complex-cancer-related-neuropathic-pain\/125798 (accessed October 30, 2021."},{"issue":"3699","key":"1642_CR24","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.150.3699.971","volume":"150","author":"R Melzack","year":"1965","unstructured":"Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(3699):971\u20139.","journal-title":"Science"},{"key":"1642_CR25","doi-asserted-by":"crossref","unstructured":"Elman I, Borsook D. Common brain mechanisms of chronic pain and addiction, Neuron, vol. 89, no. 1, pp. 11\u201336, 2016.","DOI":"10.1016\/j.neuron.2015.11.027"},{"key":"1642_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fncel.2014.00031","volume":"8","author":"S Elramah","year":"2014","unstructured":"Elramah S, Landry M, Favereaux A. MicroRNAs regulate neuronal plasticity and are involved in pain mechanisms. Front Cell Neurosci. 2014;8:31.","journal-title":"Front Cell Neurosci"},{"key":"1642_CR27","doi-asserted-by":"crossref","unstructured":"Ye Y, Xu H, Su X, He X. Role of microRNA in governing synaptic plasticity, Neural plasticity, vol. 2016, 2016.","DOI":"10.1155\/2016\/4959523"},{"key":"1642_CR28","doi-asserted-by":"crossref","unstructured":"M\u00f8ller AR. Neural plasticity and disorders of the nervous system. Cambridge University Press; 2006.","DOI":"10.1017\/CBO9780511616228"},{"key":"1642_CR29","doi-asserted-by":"crossref","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions, cell, vol. 136, no. 2, pp. 215\u2013233, 2009.","DOI":"10.1016\/j.cell.2009.01.002"},{"issue":"1","key":"1642_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-10224-1","volume":"7","author":"S Elramah","year":"2017","unstructured":"Elramah S, et al. Spinal miRNA-124 regulates synaptopodin and nociception in an animal model of bone cancer pain. Sci Rep. 2017;7(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"11","key":"1642_CR31","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jpain.2009.09.001","volume":"10","author":"I Tracey","year":"2009","unstructured":"Tracey I, Bushnell MC. How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J pain. 2009;10(11):1113\u201320.","journal-title":"J pain"},{"issue":"4","key":"1642_CR32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMsr1706626","volume":"377","author":"ND Volkow","year":"2017","unstructured":"Volkow ND, Collins FS. The role of science in addressing the opioid crisis. N Engl J Med. 2017;377(4):391\u20134.","journal-title":"N Engl J Med"},{"issue":"7","key":"1642_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJMsa1610524","volume":"376","author":"ML Barnett","year":"2017","unstructured":"Barnett ML, Olenski AR, Jena AB. Opioid-prescribing patterns of emergency physicians and risk of long-term use. N Engl J Med. 2017;376(7):663\u201373.","journal-title":"N Engl J Med"},{"issue":"3","key":"1642_CR34","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jpainsymman.2009.06.001","volume":"38","author":"H Knotkova","year":"2009","unstructured":"Knotkova H, Fine PG, Portenoy RK. Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manag. 2009;38(3):426\u201339.","journal-title":"J Pain Symptom Manag"},{"issue":"5","key":"1642_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/0885-3924(95)90924-C","volume":"10","author":"E Bruera","year":"1995","unstructured":"Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manag. 1995;10(5):378\u201384.","journal-title":"J Pain Symptom Manag"},{"issue":"9","key":"1642_CR36","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G","volume":"86","author":"S Mercadante","year":"1999","unstructured":"Mercadante S. Opioid rotation for cancer pain: rationale and clinical aspects. Cancer: Interdisciplinary Int J Am Cancer Soc. 1999;86(9):1856\u201366.","journal-title":"Cancer: Interdisciplinary Int J Am Cancer Soc"},{"key":"1642_CR37","doi-asserted-by":"crossref","unstructured":"Fine PG, Portenoy RK, Evidence AHEP. Establishing best practices for opioid rotation: conclusions of an expert panel, Journal of pain and symptom management, vol. 38, no. 3, pp. 418\u2013425, 2009.","DOI":"10.1016\/j.jpainsymman.2009.06.002"},{"issue":"2","key":"1642_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","volume":"14","author":"M Lee","year":"2011","unstructured":"Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14(2):145.","journal-title":"Pain Physician"},{"key":"1642_CR39","doi-asserted-by":"crossref","unstructured":"Richebe P, Cahana A, Rivat C. Tolerance and opioid-induced hyperalgesia. Is a divorce imminent? Pain, vol. 153, no. 8, pp. 1547\u20131548, 2012.","DOI":"10.1016\/j.pain.2012.05.002"},{"issue":"11","key":"1642_CR40","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1172\/JCI42843","volume":"120","author":"AE Dubin","year":"2010","unstructured":"Dubin AE, Patapoutian A. Nociceptors: the sensors of the pain pathway. J Clin Investig. 2010;120(11):3760\u201372.","journal-title":"J Clin Investig"},{"issue":"3","key":"1642_CR41","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/oxfordjournals.bmb.a072503","volume":"47","author":"G Hanks","year":"1991","unstructured":"Hanks G. Opioid-responsive and opioid-non-responsive pain in cancer. Br Med Bull. 1991;47(3):718\u201331.","journal-title":"Br Med Bull"},{"key":"1642_CR42","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/978-3-540-29805-2_2966","volume-title":"Encyclopedia of Pain","author":"S Mercadante","year":"2007","unstructured":"Mercadante S. Opioid responsiveness in Cancer Pain Management. In: Schmidt RF, Willis WD, editors. Encyclopedia of Pain. Berlin, Heidelberg: Springer Berlin Heidelberg; 2007. pp. 1559\u201361."},{"key":"1642_CR43","doi-asserted-by":"crossref","unstructured":"Davis MP. Drug management of visceral pain: concepts from basic research, Pain research and treatment, vol. 2012, no. 1, p. 265605, 2012.","DOI":"10.1155\/2012\/265605"},{"issue":"1","key":"1642_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/SPC.0b013e32834f6ec9","volume":"6","author":"S Sikandar","year":"2012","unstructured":"Sikandar S, Dickenson AH. Visceral pain: the ins and outs, the ups and downs. Curr Opin Support Palliat Care. 2012;6(1):17\u201326.","journal-title":"Curr Opin Support Palliat Care"},{"key":"1642_CR45","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, et al. Management of cancer pain in adult patients: ESMO Clinical Practice guidelines. Ann Oncol. 2018;29:iv166\u201391.","journal-title":"Ann Oncol"},{"issue":"10","key":"1642_CR46","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jpain.2008.05.005","volume":"9","author":"A Tsang","year":"2008","unstructured":"Tsang A, et al. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J pain. 2008;9(10):883\u201391.","journal-title":"J pain"},{"key":"1642_CR47","doi-asserted-by":"publisher","unstructured":"Bu\u0142dy\u015b K, et al. What do we know about nociplastic pain? Healthcare. 2023;11(12):1794. MDPI. https:\/\/doi.org\/10.3390\/healthcare11121794","DOI":"10.3390\/healthcare11121794"},{"key":"1642_CR48","doi-asserted-by":"crossref","unstructured":"Mao J. Challenges of managing chronic pain. Volume 356. ed: British Medical Journal Publishing Group; 2017.","DOI":"10.1136\/bmj.j741"},{"key":"1642_CR49","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/S0002-9343(96)00133-7","volume":"101","author":"JA Markenson","year":"1996","unstructured":"Markenson JA. Mechanisms of chronic pain. Am J Med. 1996;101:S6\u201318.","journal-title":"Am J Med"},{"key":"1642_CR50","doi-asserted-by":"crossref","unstructured":"Nijs J, Malfliet A, Nishigami T. Nociplastic pain and central sensitization in patients with chronic pain conditions: a terminology update for clinicians. Braz J Phys Ther, 27, 3, 2023.","DOI":"10.1016\/j.bjpt.2023.100518"},{"issue":"5","key":"1642_CR51","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S2665-9913(21)00032-1","volume":"3","author":"J Nijs","year":"2021","unstructured":"Nijs J, et al. Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021;3(5):e383\u201392.","journal-title":"Lancet Rheumatol"},{"key":"1642_CR52","doi-asserted-by":"crossref","unstructured":"Martucci KT, Ng P, Mackey S. Neuroimaging chronic pain: what have we learned and where are we going? Future neurology, vol. 9, no. 6, pp. 615\u2013626, 2014.","DOI":"10.2217\/fnl.14.57"},{"key":"1642_CR53","doi-asserted-by":"crossref","unstructured":"Zambreanu L, Wise RG, Brooks JC, Iannetti GD, Tracey I. A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging, Pain, vol. 114, no. 3, pp. 397\u2013407, 2005.","DOI":"10.1016\/j.pain.2005.01.005"},{"issue":"1","key":"1642_CR54","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/bja\/aet153","volume":"111","author":"M Al-Hashimi","year":"2013","unstructured":"Al-Hashimi M, Scott S, Thompson J, Lambert D. Opioids and immune modulation: more questions than answers. Br J Anaesth. 2013;111(1):80\u20138.","journal-title":"Br J Anaesth"},{"key":"1642_CR55","doi-asserted-by":"crossref","unstructured":"Sacerdote P. Opioids and the immune system, Palliative medicine, vol. 20, no. 8_suppl, pp. 9\u201315, 2006.","DOI":"10.1191\/0269216306pm1124oa"},{"issue":"14","key":"1642_CR56","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/bph.13750","volume":"175","author":"LM Plein","year":"2018","unstructured":"Plein LM, Rittner HL. Opioids and the immune system\u2013friend or foe. Br J Pharmacol. 2018;175(14):2717\u201325.","journal-title":"Br J Pharmacol"},{"key":"1642_CR57","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.neuroimage.2016.08.038","volume":"146","author":"H Sims-Williams","year":"2017","unstructured":"Sims-Williams H, et al. Deep brain stimulation of the periaqueductal gray releases endogenous opioids in humans. NeuroImage. 2017;146:833\u201342.","journal-title":"NeuroImage"},{"issue":"18","key":"1642_CR58","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1523\/JNEUROSCI.3862-14.2015","volume":"35","author":"E Navratilova","year":"2015","unstructured":"Navratilova E, et al. Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain. J Neurosci. 2015;35(18):7264\u201371.","journal-title":"J Neurosci"},{"key":"1642_CR59","doi-asserted-by":"crossref","unstructured":"Banerjee S et al. Morphine induced exacerbation of sepsis is mediated by tempering endotoxin tolerance through modulation of miR-146a, Scientific reports, vol. 3, no. 1, p. 1977, 2013.","DOI":"10.1038\/srep01977"},{"key":"1642_CR60","unstructured":"Waldron D, Grummell M, Daniels F, Mannion E. A retrospective review to test the hypothesis that opioid toxicity, developing in an otherwise stable patient heralds imminent sepsis. Palliat Med, 22, 2008."},{"key":"1642_CR61","doi-asserted-by":"crossref","unstructured":"McLymont N, Glover GW. Scoring systems for the characterization of sepsis and associated outcomes. Annals Translational Med, 4, 24, 2016.","DOI":"10.21037\/atm.2016.12.53"},{"issue":"6","key":"1642_CR62","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/emermed-2017-207120","volume":"35","author":"R Goulden","year":"2018","unstructured":"Goulden R, et al. qSOFA, SIRS and NEWS for predicting inhospital mortality and ICU admission in emergency admissions treated as sepsis. Emerg Med J. 2018;35(6):345\u20139.","journal-title":"Emerg Med J"},{"issue":"1","key":"1642_CR63","doi-asserted-by":"publisher","first-page":"e8791","DOI":"10.1371\/journal.pone.0008791","volume":"5","author":"E Glattard","year":"2010","unstructured":"Glattard E, et al. Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils. PLoS ONE. 2010;5(1):e8791.","journal-title":"PLoS ONE"},{"issue":"4","key":"1642_CR64","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jpainsymman.2011.10.013","volume":"44","author":"SB LeGrand","year":"2012","unstructured":"LeGrand SB. Delirium in palliative medicine: a review. J Pain Symptom Manag. 2012;44(4):583\u201394.","journal-title":"J Pain Symptom Manag"},{"issue":"11","key":"1642_CR65","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1200\/JCO.2011.39.8784","volume":"30","author":"W Breitbart","year":"2012","unstructured":"Breitbart W, Alici Y. Evidence-based treatment of delirium in patients with cancer. J Clin Oncol. 2012;30(11):1206.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1642_CR66","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/00000542-200510000-00016","volume":"103","author":"NI Osman","year":"2005","unstructured":"Osman NI, Baghdoyan HA, Lydic R. Morphine inhibits acetylcholine release in rat prefrontal cortex when delivered systemically or by microdialysis to basal forebrain. Anesthesiology: J Am Soc Anesthesiologists. 2005;103(4):779\u201387.","journal-title":"Anesthesiology: J Am Soc Anesthesiologists"},{"key":"1642_CR67","doi-asserted-by":"crossref","unstructured":"Taylor AM, Becker S, Schweinhardt P, Cahill C. Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction, Pain, vol. 157, no. 6, p. 1194, 2016.","DOI":"10.1097\/j.pain.0000000000000494"},{"issue":"11","key":"1642_CR68","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.tins.2015.09.003","volume":"38","author":"E Navratilova","year":"2015","unstructured":"Navratilova E, Atcherley CW, Porreca F. Brain circuits encoding reward from pain relief. Trends Neurosci. 2015;38(11):741\u201350.","journal-title":"Trends Neurosci"},{"issue":"5666","key":"1642_CR69","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1126\/science.1093360","volume":"303","author":"MA Ungless","year":"2004","unstructured":"Ungless MA, Magill PJ, Bolam JP. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science. 2004;303(5666):2040\u20132.","journal-title":"Science"},{"key":"1642_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1054-3589(06)54001-3","volume":"54","author":"S Enna","year":"2006","unstructured":"Enna S, McCarson KE. The role of GABA in the mediation and perception of pain. Adv Pharmacol. 2006;54:1\u201327.","journal-title":"Adv Pharmacol"},{"issue":"4","key":"1642_CR71","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/2049463714545136","volume":"8","author":"S Falk","year":"2014","unstructured":"Falk S, Bannister K, Dickenson AH. Cancer pain physiology. Br J pain. 2014;8(4):154\u201362.","journal-title":"Br J pain"},{"key":"1642_CR72","unstructured":"Kearney M. Mortally wounded: Stories of soul pain, death and healing. Marino, 1996."},{"key":"1642_CR73","doi-asserted-by":"publisher","first-page":"263235242211252","DOI":"10.1177\/26323524221125244","volume":"16","author":"CA Gomes-Ferraz","year":"2022","unstructured":"Gomes-Ferraz CA, Rezende G, Fagundes AA, d. MMR, De Carlo P. Assessment of total pain in people in oncologic palliative care: integrative literature review. Palliat care Social Pract. 16(2022):26323524221125244.","journal-title":"Palliat care Social Pract"},{"issue":"9165","key":"1642_CR74","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(99)01310-0","volume":"353","author":"RK Portenoy","year":"1999","unstructured":"Portenoy RK, Lesage P. Management of cancer pain. Lancet. 1999;353(9165):1695\u2013700.","journal-title":"Lancet"},{"key":"1642_CR75","doi-asserted-by":"crossref","unstructured":"McInerney V, Mannion E, Molony MK, Reilly L, Waldron D. An Intervention Using Quality of Life and Symptom Information as a clinical Tool in patients with Advanced Cancer. Int J Innovative Res Med Sci, 4, 08, pp. 517 to 524\u2013\u2009517 to 524, 2019.","DOI":"10.23958\/ijirms\/vol04-i08\/740"},{"issue":"11","key":"1642_CR76","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1200\/JCO.1999.17.11.3603","volume":"17","author":"D Waldron","year":"1999","unstructured":"Waldron D, O\u2019Boyle CA, Kearney M, Moriarty M, Carney D. Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol. 1999;17(11):3603\u201311.","journal-title":"J Clin Oncol"},{"key":"1642_CR77","unstructured":"S. LD. 2020 Top Stories in Metastatic Breast Cancer: Chemotherapy at the End of Life\u2014We Can Do Better by Our Patients. Practive Update - Metastatic Breast Cancer. https:\/\/www.practiceupdate.com\/content\/2020-top-stories-in-metastatic-breast-cancer-chemotherapy-at-the-end-of-life-we-can-do-better-by-our-patients\/109047 (accessed."},{"key":"1642_CR78","doi-asserted-by":"crossref","unstructured":"Mannion E, Gilmartin J, McInerney V, Molony MK, Basquille ME, Waldron D. Exploring the Innate Human potential for positive adaptation in the Face of Impending Mortality: is there a response shift in subjective quality of life over Time in a group of patients with Lung Cancer receiving Palliative Treatment? Int J Innovative Res Med Sci, 5, 05, pp. 160 to 168\u2013\u2009160 to 168, 2020.","DOI":"10.23958\/ijirms\/vol05-i05\/880"},{"issue":"7","key":"1642_CR79","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1046\/j.1464-410X.2003.04462.x","volume":"92","author":"J Rees","year":"2003","unstructured":"Rees J, Waldron D, O\u2019Boyle C, Ewings P, MacDonagh R. Prospective vs retrospective assessment of lower urinary tract symptoms in patients with advanced prostate cancer: the effect of \u2018response shift\u2019. BJU Int. 2003;92(7):703\u20136.","journal-title":"BJU Int"},{"issue":"6","key":"1642_CR80","first-page":"514","volume":"56","author":"G Vargas-Schaffer","year":"2010","unstructured":"Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician. 2010;56(6):514\u20137.","journal-title":"Can Fam Physician"},{"key":"1642_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.01.038","volume":"149","author":"M Bawor","year":"2015","unstructured":"Bawor M, et al. Testosterone suppression in opioid users: a systematic review and meta-analysis. Drug Alcohol Depend. 2015;149:1\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"1642_CR82","doi-asserted-by":"crossref","unstructured":"Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids, Cancer, vol. 100, no. 4, pp. 851\u2013858, 2004.","DOI":"10.1002\/cncr.20028"},{"issue":"6","key":"1642_CR83","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bja\/aen094","volume":"100","author":"KT Pattinson","year":"2008","unstructured":"Pattinson KT. Opioids and the control of respiration. Br J Anaesth. 2008;100(6):747\u201358.","journal-title":"Br J Anaesth"},{"issue":"1","key":"1642_CR84","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jpain.2010.05.006","volume":"12","author":"LF Chu","year":"2011","unstructured":"Chu LF, Dairmont J, Zamora AK, Young CA, Angst MS. The endogenous opioid system is not involved in modulation of opioid-induced hyperalgesia. J Pain. 2011;12(1):108\u201315.","journal-title":"J Pain"},{"key":"1642_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-328X(01)00332-1","volume":"98","author":"T Sakurada","year":"2002","unstructured":"Sakurada T, et al. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors. Mol Brain Res. 2002;98:1\u20132.","journal-title":"Mol Brain Res"},{"key":"1642_CR86","unstructured":"Loeser JD. Bonica\u2019s Management of Pain 3rd edition. Lippincott Williams & Wilkins Publishers, 2001."},{"key":"1642_CR87","doi-asserted-by":"crossref","unstructured":"Noordenbos W. Some historical aspects, Pain, vol. 29, no. 2, pp. 141\u2013150, 1987.","DOI":"10.1016\/0304-3959(87)91031-1"},{"key":"1642_CR88","doi-asserted-by":"crossref","unstructured":"Mendell LM. Constructing and deconstructing the gate theory of pain, Pain\u00ae, vol. 155, no. 2, pp. 210\u2013216, 2014.","DOI":"10.1016\/j.pain.2013.12.010"},{"issue":"3","key":"1642_CR89","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1113\/jphysiol.1967.sp008227","volume":"190","author":"PR Burgess","year":"1967","unstructured":"Burgess PR, Perl E. Myelinated afferent fibres responding specifically to noxious stimulation of the skin. J Physiol. 1967;190(3):541\u201362.","journal-title":"J Physiol"},{"issue":"3","key":"1642_CR90","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/cne.901770305","volume":"177","author":"T Kumazawa","year":"1978","unstructured":"Kumazawa T, Perl E. Excitation of marginal and substantia gelatinosa neurons in the primate spinal cord: indications of their place in dorsal horn functional organization. J Comp Neurol. 1978;177(3):417\u201334.","journal-title":"J Comp Neurol"},{"issue":"3","key":"1642_CR91","doi-asserted-by":"publisher","first-page":"101415","DOI":"10.1016\/j.berh.2019.04.007","volume":"33","author":"A-P Trouvin","year":"2019","unstructured":"Trouvin A-P, Perrot S. New concepts of pain. Best Pract Res Clin Rheumatol. 2019;33(3):101415.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1642_CR92","unstructured":"Dickenson AH, Editorial I. Gate Control Theory of pain stands the test of time. Oxford University Press; 2002."},{"key":"1642_CR93","doi-asserted-by":"publisher","unstructured":"Hanks G, Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001;84:587\u2013593. https:\/\/doi.org\/10.1054\/bjoc.2001.1680","DOI":"10.1054\/bjoc.2001.1680"},{"key":"1642_CR94","doi-asserted-by":"crossref","unstructured":"Gustafsson M, Silva V, Valeiro C, Joaquim J, van Hunsel F, Matos C. Misuse, Abuse and Medication Errors\u2019 Adverse Events Associated with Opioids\u2014A Systematic Review, Pharmaceuticals, vol. 17, no. 8, p. 1009, 2024.","DOI":"10.3390\/ph17081009"},{"issue":"1","key":"1642_CR95","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40360-023-00681-y","volume":"24","author":"J Ni","year":"2023","unstructured":"Ni J, Tang X, Chen L. Medication overdose data analysis: a review of medication error reports in the FDA adverse event reporting system (FAERS). BMC Pharmacol Toxicol. 2023;24(1):41.","journal-title":"BMC Pharmacol Toxicol"},{"key":"1642_CR96","unstructured":"Jones J. Gosport War Memorial Hospital: the report of the Gosport Independent Panel. Report no. HC1084, ed, 2018."},{"key":"1642_CR97","unstructured":"Campbell D. Gosport hospital opioid deaths: police identify 24 suspects. theguardian.com. https:\/\/www.theguardian.com\/uk-news\/2024\/oct\/10\/police-pass-files-to-cps-over-deaths-at-gosport-war-memorial-hospital?CMP=share_btn_url (accessed 2024)."},{"key":"1642_CR98","unstructured":"McGreal C. American overdose: The opioid tragedy in three acts. PublicAffairs, 2018."},{"key":"1642_CR99","unstructured":"Keefe PR. Empire of pain: The secret history of the Sackler dynasty. Anchor, 2021."},{"key":"1642_CR100","unstructured":"Protecting Patients. (accessed). https:\/\/www.irishtimes.com\/opinion\/protecting-patients-1.1136282"},{"key":"1642_CR101","unstructured":"Joseph A, Silverman E. Faced with an outcry over limits on opioids, authors of CDC guidelines acknowledge they\u2019ve been misapplied. STAT. 2019. [Citation] https:\/\/www.statnews.com\/2019\/04\/24\/cdc-opioid-prescribing-guidelines-misapplied"},{"issue":"6","key":"1642_CR102","doi-asserted-by":"publisher","first-page":"e1002165","DOI":"10.1371\/journal.pbio.1002165","volume":"13","author":"LP Freedman","year":"2015","unstructured":"Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLoS Biol. 2015;13(6):e1002165.","journal-title":"PLoS Biol"},{"key":"1642_CR103","doi-asserted-by":"crossref","unstructured":"Hemming K, Eldridge S, Forbes G, Weijer C, Taljaard M. How to design efficient cluster randomised trials, bmj, vol. 358, p. j3064, 2017.","DOI":"10.1136\/bmj.j3064"},{"issue":"1","key":"1642_CR104","doi-asserted-by":"publisher","first-page":"e0190362","DOI":"10.1371\/journal.pone.0190362","volume":"13","author":"R Zhang","year":"2018","unstructured":"Zhang R, et al. Prescription opioids are associated with higher mortality in patients diagnosed with sepsis: a retrospective cohort study using electronic health records. PLoS ONE. 2018;13(1):e0190362.","journal-title":"PLoS ONE"},{"issue":"3","key":"1642_CR105","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3390\/ijms23031097","volume":"23","author":"Y Abu","year":"2022","unstructured":"Abu Y, Vitari N, Yan Y, Roy S. Opioids and Sepsis: elucidating the role of the Microbiome and microRNA-146. Int J Mol Sci. 2022;23(3):1097.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1642_CR106","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0006-8993(75)90391-1","volume":"88","author":"J Hughes","year":"1975","unstructured":"Hughes J. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res. 1975;88(2):295\u2013308.","journal-title":"Brain Res"},{"issue":"5679","key":"1642_CR107","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/275450a0","volume":"275","author":"JW Holaday","year":"1978","unstructured":"Holaday JW, Faden AI. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature. 1978;275(5679):450\u20131.","journal-title":"Nature"},{"key":"1642_CR108","first-page":"93","volume":"125","author":"R Bone","year":"1982","unstructured":"Bone R, Jacobs E, Wilson F, Hiller F. Naloxone reversal of hypotension: a clinical study. Am Rev Respir Dis. 1982;125:93.","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"1642_CR109","first-page":"669","volume":"81","author":"J Canady","year":"1989","unstructured":"Canady J, Williams W, Thompson I, Vincent GS, Hoover E. Use of naloxone in septic shock. J Natl Med Assoc. 1989;81(6):669.","journal-title":"J Natl Med Assoc"},{"key":"1642_CR110","doi-asserted-by":"crossref","unstructured":"Boeuf B et al. Naloxone for shock, Cochrane Database of Systematic Reviews, vol. 2010, no. 1, 1996.","DOI":"10.1002\/14651858.CD004443"},{"issue":"2","key":"1642_CR111","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/tcic.12.2.61.65","volume":"12","author":"M Sakaryaa","year":"2001","unstructured":"Sakaryaa M, Sakaryab A, Aydedeb H, Topcua I, Onguna B, Erhanb Y. Can naloxone be a prokinetic agent in sepsis? Clin Intensive Care. 2001;12(2):61\u20135.","journal-title":"Clin Intensive Care"},{"issue":"1","key":"1642_CR112","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/jamainternmed.2016.7491","volume":"177","author":"MR Agar","year":"2017","unstructured":"Agar MR, et al. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med. 2017;177(1):34\u201342.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"1642_CR113","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jpainsymman.2003.07.002","volume":"27","author":"N Slatkin","year":"2004","unstructured":"Slatkin N, Rhiner M. Treatment of opioid-induced delirium with acetylcholinesterase inhibitors: a case report. J Pain Symptom Manag. 2004;27(3):268\u201373.","journal-title":"J Pain Symptom Manag"},{"issue":"26","key":"1642_CR114","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1056\/NEJMoa2211868","volume":"387","author":"NC Andersen-Ranberg","year":"2022","unstructured":"Andersen-Ranberg NC, et al. Haloperidol for the treatment of delirium in ICU patients. N Engl J Med. 2022;387(26):2425\u201335.","journal-title":"N Engl J Med"},{"issue":"1","key":"1642_CR115","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.1038\/s41598-024-56675-1","volume":"14","author":"SH Yoo","year":"2024","unstructured":"Yoo SH, et al. Opioid use and subsequent delirium risk in patients with advanced cancer in palliative care: a multicenter registry study. Sci Rep. 2024;14(1):6004.","journal-title":"Sci Rep"},{"key":"1642_CR116","doi-asserted-by":"publisher","first-page":"174480691878125","DOI":"10.1177\/1744806918781259","volume":"14","author":"C Qi","year":"2018","unstructured":"Qi C, et al. Chronic inflammatory pain decreases the glutamate vesicles in presynaptic terminals of the nucleus accumbens. Mol Pain. 2018;14:1744806918781259.","journal-title":"Mol Pain"},{"key":"1642_CR117","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.expneurol.2016.09.005","volume":"285","author":"Y-J Huang","year":"2016","unstructured":"Huang Y-J, Lee KH, Murphy L, Garraway SM, Grau JW. Acute spinal cord injury (SCI) transforms how GABA affects nociceptive sensitization. Exp Neurol. 2016;285:82\u201395.","journal-title":"Exp Neurol"},{"issue":"7","key":"1642_CR118","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1111\/ejn.12709","volume":"40","author":"CM Vander Weele","year":"2014","unstructured":"Vander Weele CM, et al. Rapid dopamine transmission within the nucleus accumbens: dramatic difference between morphine and oxycodone delivery. Eur J Neurosci. 2014;40(7):3041\u201354.","journal-title":"Eur J Neurosci"},{"issue":"7","key":"1642_CR119","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1111\/ejn.12726","volume":"40","author":"DP Covey","year":"2014","unstructured":"Covey DP, Cheer JF. Pick your poison: not all opioids are created equal in the eyes of dopamine (Commentary on Vander Weele. et al) Eur J Neurosci. 2014;40(7):3040.","journal-title":"et al) Eur J Neurosci"},{"key":"1642_CR120","doi-asserted-by":"crossref","unstructured":"Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers, Neuropsychopharmacology, vol. 33, no. 5, pp. 1179\u20131191, 2008.","DOI":"10.1038\/sj.npp.1301479"},{"issue":"4","key":"1642_CR121","doi-asserted-by":"publisher","first-page":"49097","DOI":"10.21037\/apm.2019.08.01","volume":"8","author":"J Gaertner","year":"2019","unstructured":"Gaertner J, Boehlke C, Simone CB II, and, Hui D. Early palliative care and the opioid crisis: ten pragmatic steps towards a more rational use of opioids. Annals Palliat Med. 2019;8(4):49097\u2013497.","journal-title":"Annals Palliat Med"},{"key":"1642_CR122","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1200\/EDBK_100020","volume":"39","author":"S Dalal","year":"2019","unstructured":"Dalal S, Bruera E. Pain management for patients with advanced cancer in the opioid epidemic era. Am Soc Clin Oncol Educational Book. 2019;39:24\u201335.","journal-title":"Am Soc Clin Oncol Educational Book"},{"issue":"27","key":"1642_CR123","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","volume":"34","author":"JA Paice","year":"2016","unstructured":"Paice JA, et al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34(27):3325\u201345.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1642_CR124","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.eujps.2011.08.013","volume":"5","author":"K McGreevy","year":"2011","unstructured":"McGreevy K, Bottros MM, Raja SN. Preventing chronic pain following acute pain: risk factors, preventive strategies, and their efficacy. Eur J pain Supplements. 2011;5(2):365\u201376.","journal-title":"Eur J pain Supplements"},{"key":"1642_CR125","doi-asserted-by":"crossref","unstructured":"van den Beuken-van MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. High prevalence of pain in patients with cancer in a large population-based study in The Netherlands, Pain, vol. 132, no. 3, pp. 312\u2013320, 2007.","DOI":"10.1016\/j.pain.2007.08.022"},{"key":"1642_CR126","doi-asserted-by":"publisher","unstructured":"Arcidiacono PGG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 3(2011). https:\/\/doi.org\/10.1002\/14651858.CD007519.pub2","DOI":"10.1002\/14651858.CD007519.pub2"},{"key":"1642_CR127","doi-asserted-by":"publisher","unstructured":"Hyland SJ, et al. Perioperative pain management and opioid stewardship: a practical guide. Healthcare. 2021;9(3):333. MDPI. https:\/\/doi.org\/10.3390\/healthcare9030333","DOI":"10.3390\/healthcare9030333"},{"key":"1642_CR128","doi-asserted-by":"crossref","unstructured":"Dahan A, Overdyk F, Smith T, Aarts L, Niesters M. Pharmacovigilance: a review of opioid-induced respiratory depression in chronic pain patients. Pain Physician, 16, 2, pp. E85-94, 2013.","DOI":"10.36076\/ppj.2013\/16\/E85"},{"issue":"1","key":"1642_CR129","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","volume":"112","author":"A Dahan","year":"2010","unstructured":"Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology: J Am Soc Anesthesiologists. 2010;112(1):226\u201338.","journal-title":"Anesthesiology: J Am Soc Anesthesiologists"},{"issue":"5","key":"1642_CR130","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/ALN.0000000000002184","volume":"128","author":"A Dahan","year":"2018","unstructured":"Dahan A, van der Schrier R, Smith T, Aarts L, van Velzen M, Niesters M. Averting opioid-induced respiratory depression without affecting analgesia. Anesthesiology: J Am Soc Anesthesiologists. 2018;128(5):1027\u201337.","journal-title":"Anesthesiology: J Am Soc Anesthesiologists"},{"key":"1642_CR131","unstructured":"Agency USDE. DEA. One pill can kill. United States Drug Enforcement Agency. https:\/\/www.dea.gov\/onepill (accessed."},{"key":"1642_CR132","unstructured":"Agency USDE. DEA. One pill can kill social media campaign. United States Drug Enforcement Agency. https:\/\/www.dea.gov\/dea-one-pill-can-kill-social-media-campaign (accessed."},{"issue":"3","key":"1642_CR133","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/082585971002600306","volume":"26","author":"K Jackson","year":"2010","unstructured":"Jackson K, et al. The effectiveness and adverse effects profile of burst ketamine in refractory cancer pain: the VCOG PM 1\u2013\u200900 study. J Palliat Care. 2010;26(3):176\u201383.","journal-title":"J Palliat Care"},{"issue":"4","key":"1642_CR134","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/2049463716657363","volume":"10","author":"RM Langford","year":"2016","unstructured":"Langford RM, Knaggs R, Farquhar-Smith P, Dickenson AH. Is tapentadol different from classical opioids? A review of the evidence. Br J pain. 2016;10(4):217\u201321.","journal-title":"Br J pain"},{"issue":"11","key":"1642_CR135","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1185\/03007995.2012.739151","volume":"28","author":"S Mercadante","year":"2012","unstructured":"Mercadante S, et al. Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin. 2012;28(11):1775\u20139.","journal-title":"Curr Med Res Opin"},{"key":"1642_CR136","doi-asserted-by":"publisher","unstructured":"Romualdi P, Grilli M, Canonico PL, Collino M, Dickenson AH. Pharmacological rationale for tapentadol therapy: a review of new evidence. J pain Res. 2019:1513\u201320. https:\/\/doi.org\/10.2147\/JPR.S190160","DOI":"10.2147\/JPR.S190160"},{"issue":"3","key":"1642_CR137","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1526-4637.2004.04037.x","volume":"5","author":"AW Burton","year":"2004","unstructured":"Burton AW, et al. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004;5(3):239\u201347.","journal-title":"Pain Med"},{"issue":"10","key":"1642_CR138","doi-asserted-by":"publisher","first-page":"e1002396","DOI":"10.1371\/journal.pmed.1002396","volume":"14","author":"T Gomes","year":"2017","unstructured":"Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case\u2013control study. PLoS Med. 2017;14(10):e1002396.","journal-title":"PLoS Med"},{"issue":"2","key":"1642_CR139","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0022-3565(24)38234-5","volume":"289","author":"AM Davis","year":"1999","unstructured":"Davis AM, Inturrisi CE. d-Methadone blocks morphine tolerance andn-methyl-D-aspartate-induced hyperalgesia. J Pharmacol Exp Ther. 1999;289(2):1048\u201353.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"1642_CR140","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJMra1800222","volume":"380","author":"JJ Martyn","year":"2019","unstructured":"Martyn JJ, Mao J, Bittner EA. Opioid tolerance in critical illness. N Engl J Med. 2019;380(4):365\u201378.","journal-title":"N Engl J Med"},{"key":"1642_CR141","doi-asserted-by":"crossref","unstructured":"Chino FL, Kamal A, Chino JP. Opioid-associated deaths in patients with cancer: a population study of the opioid epidemic over the past 10 years. American Society of Clinical Oncology; 2018.","DOI":"10.1200\/JCO.2018.36.30_suppl.230"},{"issue":"1","key":"1642_CR142","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0885-3924(02)00542-0","volume":"25","author":"C-C Lin","year":"2003","unstructured":"Lin C-C, Lai Y-L, Ward SE. Effect of cancer pain on performance status, mood states, and level of hope among Taiwanese cancer patients. J Pain Symptom Manag. 2003;25(1):29\u201337.","journal-title":"J Pain Symptom Manag"},{"issue":"13","key":"1642_CR143","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra1507771","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, McLellan AT. Opioid abuse in chronic pain\u2014misconceptions and mitigation strategies. N Engl J Med. 2016;374(13):1253\u201363.","journal-title":"N Engl J Med"},{"issue":"1","key":"1642_CR144","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1634\/theoncologist.2010-0161","volume":"16","author":"S Dalal","year":"2011","unstructured":"Dalal S, et al. Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist. 2011;16(1):105\u201311.","journal-title":"Oncologist"},{"key":"1642_CR145","unstructured":"Organization WH. WHO. Palliative Care. World Health Organization. WHO. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/palliative-care (accessed."},{"key":"1642_CR146","unstructured":"Gawande A. Being mortal: Medicine and what matters in the end. Metropolitan Books; 2014."}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01642-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-025-01642-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01642-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:04:18Z","timestamp":1747285458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-025-01642-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":146,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1642"],"URL":"https:\/\/doi.org\/10.1007\/s11912-025-01642-w","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"18 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}